Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Pharmacy / Pharmacist News

Prescription Drug Sales Growth Expected To Slow In 2008, IMS Report Says

Main Category: Pharmacy / Pharmacist
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 02 Nov 2007 - 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:4 stars

4 (1 votes)

Article Opinions: 0 posts

Sales growth for prescription drugs in 2008 is expected to increase at the lowest rate in decades, according to an annual forecast released Thursday by health care information and consulting firm IMS Health, the Wall Street Journal reports. The report projects that U.S. sales of brand-name and generic prescription drugs in 2008 will experience growth rates between 4% and 5%, compared with rates between 5% and 6% this year.

The estimate puts U.S. sales at as much as $305 billion. Worldwide sales in 2008 are expected to increase to as much as $745 billion, a growth rate of 5% to 6%, which also is a deceleration from 2007 (Whalen, Wall Street Journal, 11/1). In addition, according to the report, the U.S. will see its worldwide market share for drugs decrease to one-third, compared with half of global market share two years ago, the AP/Washington Post reports.

IMS said the slowing sales growth in part is caused by increased FDA regulation and scrutiny of new drugs seeking approval. IMS predicts slower approvals and more warning labels in the future (Perrone, AP/Washington Post, 11/1). According to the Journal, another factor is brand-name drugs losing their hold on the market as patents expire and generic versions are approved. IMS estimates that generic drugs will fill two-thirds of U.S. prescriptions in 2008, compared with half in 2003 (Wall Street Journal, 11/1).

Murray Aitken, senior vice president at IMS, said, "What we see is more information on drug usage becoming available and being mined to find risks and safety issues," adding, "Overall, this means more uncertainty for companies, as well as for their ability to get products to patients" (AP/Washington Post, 11/1).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
What Is Amoxicillin? What Does Amoxicillin Treat?
22 Jul 2009
Amoxicillin - better known by brand names such as Amoxil, Dispermox, Trimox, and Alphamox - is an antibiotic drug in the penicillin group that fights bacteria and bacterial infections...


Losing Sleep As We Get Older
Losing Sleep As We Get Older

Many of us struggle with insomnia as we age. But there are ways to win the battle and get a good night's sleep.

more videos are available in our health videos section.